MGN-1331

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMGN-1331

Drug Alias NameMIDGE technology (Mologen)MGN-1331

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsVirus DiseasesLeishmaniasis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMologen Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMologen Ag

Active IndicationsN/A

Inactive IndicationsVirus DiseasesLeishmaniasis

Other Information

ATC CodeN/A